Mizuho analyst Ann Hynes maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $103 to $63.
5 Analysts Have This to Say About LivePerson
Over the past 3 months, 5 analysts have published their opinion on LivePerson (NASDAQ:LPSN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
